CMPX Compass Therapeutics Inc Com
0%
Previous Close
Open
52 Week Low
52 Week High
Market Cap
$0
Shares
61,120,062
Float
35,139,675
Enterprise Value
$0
Volume
0
Av. Daily Volume
0
Upcoming Catalysts
| Drug | Stage | Catalyst Date |
|---|---|---|
|
CTX-471
Solid Tumors
|
Phase 1
Phase 1
|
Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 14-day FREE TRIAL.
|
|
CTX-471 and trastuzumab (Herceptin)
EGFR positive tumors
|
Phase 1
Phase 1
|
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien.
|